• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. CROSSER 14S(RX)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. CROSSER 14S(RX) Back to Search Results
Catalog Number CRE14S
Device Problem Difficult To Position (1467)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/25/2014
Event Type  Injury  
Event Description
It was reported that after the recanalization catheter had been activated for 1 minute and 27 seconds in the sfa, the catheter and the guidewire advanced into the subintimal layer.The tip of the guidewire prolapsed and detached, remaining in the false lumen of the artery.The recanalization catheter was removed without incident and a stent was implanted in the vessel, opposing the guidewire tip to the wall.There was no reported pt injury.
 
Manufacturer Narrative
A further clinical review of this event was performed and identified the event to be mdr reportable as a serious injury pursuant to 21 cfr part 803.A mfg review was conducted.The lot met all released criteria.This is the only complaint reported to date for corporate lot number gfxj0877, for the issue.The investigation is inconclusive, as the sample was not returned for eval.Per the ifu, after advancing the guidewire and crosser catheter to the lesion site.The guidewire needs to be withdrawn approximately 1cm within the catheter so that the tip of the crosser catheter is the leading edge.It is likely that the user did not withdraw the guidewire into the distal tip of the crosser catheter prior to activating the crosser.Having the guidewire fully advanced through the distal tip of the crosser catheter during activation could cause the guidewire to break.Therefore, the root cause is most likely user related.The crosser catheter instructions for use (ifu) provides general instructions for use of the device, as well as warnings, precautions, and potential complications associated with the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CROSSER 14S(RX)
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
tempe AZ
Manufacturer (Section G)
CR BARD INC (GFO)
289 bay rd
queensbury NY 12804 204
Manufacturer Contact
brett curtice
1625 west 3rd st.
tempe, AZ 85281
4808949515
MDR Report Key4810660
MDR Text Key21468276
Report Number2020394-2015-00783
Device Sequence Number1
Product Code DQY
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K072776
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Other
Type of Report Initial
Report Date 04/04/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/22/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2015
Device Catalogue NumberCRE14S
Device Lot NumberGFXJ0877
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/25/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/01/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age70 YR
-
-